It is therefore certain that future research into the calcitonin family of peptides and their receptors will eventually lead to identification of prognostic markers and potential therapeutic targets that will ultimately increase the life expectancy of prostate cancer patients dramatically. The gene discussed is CALCA; the disease is prostate cancer.